I tend to stay away from speculative investments until they have proven some sort of market fit. However, I make certain exceptions for industries that I am very comfortable with. On that note, I think younger investors could allocate a small portion of their portfolio towards these types of investments, because they have the luxury of time on their side,…
Read More
The COVID-19 crisis has been difficult, to say the least. Millions are out of work as the economy prepares to contract sharply. And while stock markets have rebounded, many individual stocks are still in the dumps. As economies reopen, there are two growth companies at the top of my buy list. These businesses were crushed when the economy shuttered, yet…
Read More
Molson Coors Canada Inc. (TSX:TPX.B)(NYSE:TAP) is a Canadian icon. Last year, it generated more than $10 billion in sales. But there’s a problem: growth has stagnated. Last quarter, revenue declined by 8.7% year over year. “After a corporate restructuring in the fourth quarter of 2019 and a bevy of new products hitting the market in the New Year, Molson Coors…
Read More
Everyone knows that diversification is key to investing, as it protects investors from too much exposure into one specific sector. Having cannabis stocks in your portfolio may be a great idea if you are looking for a well-rounded portfolio. In Canada, marijuana has been legalized for medical use since 2001 and recreational use since 2018. This has allowed the industry…
Read More
Cannabis producer HEXO (TSX:HEXO)(NYSE:HEXO) announced its first-ever product export to Israel on Thursday. The company has finally found a new market for medical marijuana after several quarters of declining segment sales. A recovering HEXO stock surged more than 5% on the news as investors took notice. However, should the market celebrate this latest win? What happened? HEXO has entered a 24-month…
Read More
Investors that have lost their shirts with various Canadian cannabis stocks over the past year can attest the pain of a bubble and stock prices. Valuations are now at levels that, by some metrics, are at all-time highs. Therefore, investors ought to be more cautious with making large investments in any company right now. In this article, I’m going to…
Read More
The coronavirus crash created a ton of buying opportunities. While the rebound erased many of those options, there are still dirt-cheap stocks worth buying that could rise more than 100% over the next few months. Of course, massive upside comes with some added risk. But the two picks below look outrageously priced given the potential upside in the second half…
Read More
It’s always a good idea to avoid investment taxes. Tax-Free Savings Accounts (TFSAs) make that easy, shielding your capital from both capital gains and dividend taxes. But not every investment makes a good TFSA stock. You’ll want to choose carefully. For example, let’s say you chose to invest in Enbridge Inc due to its 7.8% dividend. With a TFSA, that…
Read More
Altria Group (NYSE:MO) is one of the largest tobacco producers in the world. Its size is truly remarkable. Last quarter, despite the onset of the COVID-19 pandemic, the company generated more than $5 billion in sales. It also produced a quarterly profit of nearly $2 billion, up 38% year over year. Those profits help service an 8.6% dividend. If you…
Read More
Big changes keep happening at Aurora Cannabis (TSX:ACB)(NYSE:ACB) this year. The marijuana producer has significantly restructured its operations and balance sheet as industry focus turns from growth to profitability. The big question for investors is whether Aurora Cannabis stock is a buy or sell after the latest restructuring update announced on Tuesday. What’s happening at Aurora Cannabis? Aurora is suspending…
Read More